Johnson & Johnson (NYSE: JNJ) was once viewed as a leader in the COVID-19 vaccine arena. In this Motley Fool Live video recorded on June 9, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not J&J is now a has-been in the COVID-19 vaccine market. Keith Speights: Reuters recently reported about another company, Johnson & Johnson.
Since the end of the Great Recession, growth stocks have pretty much left everything else eating their dust. In 2013, J.P. Morgan Asset Management released a report that compared to performance of companies that initiated and grew a dividend to companies that didn't pay a dividend over a four-decade stretch (1972-2012).
It might seem that Warren Buffett doesn't like dividends. After all, Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) has never paid a dividend. There are more stocks in Berkshire's portfolio that pay dividends than ones that don't.